Abbott Laboratories (ABT) Stock Price, Quote & News

Company Profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement ther...

Industry: Medical Devices

Sector: Healthcare

Phone: 224 667 6100

Website: www.abbott.com

Address:

100 Abbott Park Road, Abbott Park, United States

TalkMarkets Aug. 25 at 12:25 AM

Sector Watch: Now #Biotech And #Healthcare Has The Momentum As Rotation Continues $ABT $ABBV $XBI $XLV $XLK https://talkmarkets.com/article/sector-watch-now-biotech-and-healthcare-has-the-momentum-as-rotation-continues-1787617441

0 · Reply

CapitalMonk Aug. 22 at 1:49 AM

$ABT Price: $116.64 (+2.19%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.73% RSI: 80.7 | Momentum: Moderate Volume: +15.8% vs avg Volatility: 1.27% Support: $102.89 | Resistance: $116.66 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

GettnFibbywIT Aug. 21 at 7:30 PM

$ABT $XLV $SPY

0 · Reply

thingkfast Aug. 21 at 2:52 PM

$ABT March 31st - Abbott and other investors fund $575 million in WHOOP at $10.1B valuation August 18th - WHOOP partners with Grail, adding Galleri screening test for their members 🤔

0 · Reply

1212JM Aug. 21 at 12:42 PM

$ABT settlement is great news. It’s been an overhang for the last 5 years…

0 · Reply

EmbraceVolatility Aug. 21 at 4:25 AM

$ABT No pullback? I need to cover my short calls. 😠

0 · Reply

Estimize Aug. 20 at 2:18 PM

Wall St is expecting 1.42 EPS for $ABT Q3 [Reporting 10/21 BMO] http://www.estimize.com/intro/abt?chart=historical&metric_name=eps&utm_cont

0 · Reply

MeganCarlson234 Aug. 20 at 7:29 AM

$TTE $ABT $TD $TMUS $PEP TotalEnergies remains leveraged to global energy markets, Abbott benefits from healthcare and diagnostics demand, TD Bank benefits from financial activity, T-Mobile benefits from wireless subscriber growth, and PepsiCo benefits from resilient consumer demand. I'm watching energy prices, medical-device demand, credit conditions, subscriber growth, and volumes.

0 · Reply

topstockalerts Aug. 19 at 8:48 PM

Abbott Laboratories has agreed to settle its appeal of a $495 million verdict involving its specialized formula for premature infants, according to court filings in Missouri. The settlement terms were not disclosed. In 2024, a St. Louis jury found that Abbott’s infant formula contributed to an Illinois girl developing necrotizing enterocolitis (NEC), a serious intestinal disease primarily affecting premature newborns. Abbott had challenged the verdict before the Missouri Supreme Court after a state appeals court upheld it in May. About 1,000 similar lawsuits have been filed against Abbott, which makes Similac, and Mead Johnson, a Reckitt unit that produces Enfamil. More than 800 cases are consolidated in federal court in Illinois, with additional cases pending in Illinois, Missouri and Pennsylvania. NEC causes intestinal tissue death and has an estimated mortality rate above 20%. $ABT

0 · Reply

DidYouReadThis Aug. 18 at 8:24 PM

$ABT nice chart

0 · Reply

Market Cap	201.83B
Revenue (ttm)	44.33B
Net Income (ttm)	6.52B
EPS (ttm)	N/A
PE Ratio	21.70
Forward PE	20.68
Profit Margin	14.72%
Debt to Equity Ratio	0.63

Volume	5,917,000
Avg Vol	11,681,924
Day's Range	N/A - N/A
Shares Out	1.73B
Stochastic %K	93%
Beta	0.59
Analysts	Strong Sell
Price Target	$121.33